Latest posts from our Health Matters blog Join us on LinkedIn PwC UK YouTube channel Subscribe to our RSS feed Join us on Facebook Follow PwC on Twitter

08 August 2018

Global mobility in the NHS

Public sector organisations are increasingly faced with the problems of dealing with a global workforce where employees are becoming more agile and expectations of mobility are routine. This is particularly true for the NHS which employs 1.7 million people across the UK. It is the country’s biggest employer and ranks at number five globally.

07 August 2018

The gender pay gap and the NHS

With national contracts in place for pay, it might be safe to assume that the NHS would report a smaller than average gender pay gap. In fact, at 25 percent, the disparity between male and female earnings in the NHS is almost half as big again as the ONS average of 17.4 percent. But it’s not a matter of unequal pay. As with many industries, it’s the domination of senior and better paid roles by men that creates the pay gap.

30 July 2018

Making Tax Digital for VAT - Are you ready for 1 April 2019 and beyond?

Making Tax Digital – or MTD as it’s known – is the biggest shake-up in the UK tax system in a generation. It involves a range of HMRC initiatives which will see the digitisation of tax reporting for individuals and businesses. Making Tax Digital for Business (“MTDfB”) is the Government’s flagship policy to move all business-related tax reporting online with the aim of making it more accurate, more reliable and more efficient.

16 July 2018

To meet increasing demand the NHS must also transform supply

Headlines attest to the fact that the pressures on the NHS are considerable and growing. To try and arrest some of the pressures on acute settings, it’s vital that moves to transfer care to community-based settings succeed. As that transition progresses, the attention on clinical considerations is understandable and necessary. But it’s also important that the design and operation of the services and functions underpinning effective care are not overlooked.

11 July 2018

How will US Tax Reform impact EMEA pharmaceutical companies that have a presence within the US?

By Andrew Packman The 2017 tax reform reconciliation act is the most significant overhaul of the US tax code since 1986. It lowers corporate and individual rates, implements a territorial taxation system, limits the interest rate deduction for corporations, creates new taxes and adds numerous new rules. The law will...

13 June 2018

Reshaping NHS funding flows

By Mark Knight In recent months the topic of NHS finances has rarely been off the news. The NHS is under severe financial pressure and as a result is struggling to meet expected service standards. Expectations are high as the prime minister has indicated that the government is considering a...

11 June 2018

How can we build trust in the pharmaceutical and life sciences industry?

By Lucy Stapleton In pharmaceuticals and life sciences, trustworthiness is the single most important driver of reputation. However, historically the industry has been perceived to be mainly focussed on making money out of patients and interested in price rather than outcomes. Various public polls in recent months also show that...

01 June 2018

Making money work in the health and care system

Money talks. However, in the health and care system at the moment, it’s not always clear what it’s trying to say. Providers and systems are obliged to deal with a myriad of complex funding mechanisms which incentivise, at times, contradictory behaviours.

16 May 2018

Process, people and technology - the key to a successful Security Operations Centres in healthcare

Discussions about security operations centres (SOCs) often start from a very technical perspective. But that approach to managing an organisation’s security is, in many ways, now starting to look outdated. That’s because the risks posed by cyber security are not purely technical but, importantly, operational. This blog explores those risks and how to mitigate them.

03 May 2018

Preparing Supply Chains for Brexit

By Johnathon Marshall and Chris Cartmell As if UK Modern Slavery Act (MSA) compliance and the Falsified Medicines Directive (FMD) were not enough, Brexit carries enough uncertainty to keep even the most intrepid supply chain executives up at night. With the terms of a final trade deal still unclear it...

11 April 2018

Planning for Post-Deal Integration in Pharmaceutical and Life Sciences

By Jo Pisani and Cynthia Chan M&A and licensing remain the mainstay of strategy execution for pharmaceutical and life sciences companies. Although the volume of deals activity in 2017 declined by 22% vs. 2016 we see an increase in the complexity of deals given the changing market dynamics. Pharmaceutical companies...

Delivering strategic transformation - the changing role of the NHS Chair

The changing role of the NHS Chair - David Rogers, Chair at North Staffordshire Combined Healthcare NHS Trust explains how his role has changed in recent times

29 March 2018

Revolutionising health - blockchain and wearable technology

By Ailis Mone In the last of a series of blogs looking at how blockchain can transform healthcare systems and ultimately patient care, Ailis Mone, from PwC’s Blockchain team, explains how wearable technology can improve patient health. Wearable technology has taken the world by storm over the past number of...

01 March 2018

Cyber security: the risk posed by smart medical devices

As medical devices and technology  become ever more sophisticated, security becomes ever more important. Security by-design, not reactive measures, should become the guiding principle.

28 February 2018

What we need to know about NHS funding flows

The HFMA & PwC are conducting a survey to open out the discussion on what the way forward should look like. Finance managers are in a prime position to understand what’s working and what isn’t within the system as it stands – and what would support the development of an integrated health and care system. 

23 February 2018

Under lock and key. How Blockchain secures controlled drugs

In the third of a series of blogs looking at how Blockchain can transform health-care systems and patient care, Ailis Mone, from PwC’s Blockchain team, explains how the current process for controlled drugs can be improved.

08 February 2018

Why data matters to pharma

Data Integrity is a buzz word in the pharma and life sciences sector at the moment. Getting beneath the words is critical and so PwC is working with PharmaConsult to deliver the First International Conference on Data Integrity in Pharmaceuticals.

05 February 2018

Analytics in healthcare: bringing A&E performance targets into sharper focus

By Ulrich Dempfle Over the past few weeks, it’s been impossible to read, watch or hear any UK news bulletin without at least a mention of the NHS’s struggles to hit the 4-hour standard for A&E performance. On the face of it, the target seems narrow and simple. Achieving it,...

01 February 2018

Pharma R&D: How the Medicines Discovery Catapult and BIA's State of the Drug Discovery Nation 2018 report will make a real difference

By Jo Pisani The situation in the world of global pharma R&D is complex. Around the world healthcare systems are reducing their budgets but at the same time people are living longer, often with long term conditions. R&D remains the life-blood of the industry but the pressure on the system...

30 January 2018

Harnessing innovation - how to deliver transformation in the NHS

By Rt Hon Alan Milburn and Dame Jackie Daniel, Chief Executive, University Hospitals of Morecambe Bay NHS Foundation Trust Across the NHS leaders are grappling with how to make the care system sustainable. Without significant change it will not be. Today there is a ‘new normal’ of significant financial deficit...